Repeated Far Infrared Sauna Bathing in Adults With Obesity
Part of paid clinical trials in Eugene, Oregon.
- Sponsor
- University of Oregon
- Study ID
- NCT07158047
- Status
- Recruiting
Conditions
- Obesity (Disorder)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 59 Years
- Healthy Volunteers
- Not accepted
Interventions
- Heat therapy — OTHER30 sessions of far infrared sauna bathing (45-60C) for up to 45 min
Study Details
This is a clinical trial to determine if 30 sessions of far infrared sauna bathing can improve cardiovascular and metabolic function in adults with obesity.
Key Dates
- Start date
- Mar 7, 2022
- Status verified
- Mar 2026
- Primary completion
- Jun 30, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Heat therapyGroup will undergo 30 sessions of heat therapy over approximately 10 weeks. Sessions will require participants to sit in a far infrared sauna for up to 45 min for 3 to 4 times per week.
- No Intervention: Time control groupNo participation in sauna bathing. Maintain lifestyle habits for approximately 10 weeks.
Primary Outcome Measure
Blood pressure change [ Time Frame: 10 weeks ]
Central Contacts
- Christopher T Minson, PhD541-346-7583
- John R Halliwill, PhD541-346-7591
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Oregon | Eugene | Oregon | 97401 | Christopher T Minson, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Eugene, OR
By research site
Related Studies
- The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With ObesityRecruiting · University of Mississippi Medical Center · Jackson, Mississippi
- Continuous Glucose Monitoring in Metabolic SurgeryNot Yet Recruiting · Pennington Biomedical Research Center · Baton Rouge, Louisiana
- Healthy Living Anson StudyRecruiting · University of North Carolina, Chapel Hill · Chapel Hill, North Carolina
- Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)Recruiting · Nemours Children's Clinic · Jacksonville, Florida